Scientists hunt for early warning signs of kidney damage in cancer patients
NCT ID NCT06549634
Summary
This study aimed to find better ways to spot early kidney injury in people newly diagnosed with multiple myeloma who are starting a specific treatment called daratumumab. Researchers collected blood and urine samples from 20 patients to measure certain proteins that might signal kidney problems before standard tests can. The goal was to see if these new markers could help doctors detect and potentially prevent kidney damage earlier.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.